Latest in Highlight
While the drug will still cost $900 for a 12-week course of treatment, that is a fraction of the $84,000 charged for a course of treatment in the United States.
Around 12 million or 14% of Egyptians infected with disease
Egyptian scientist Tarek Hassanein has been working on the development of one of the new drugs that promise a better future for patients suffering from Hepatitis C
In Egypt, the chronic liver disease Hepatitis C is a major concern in medical circles. Specialists are recording an increasing rate of infection in the country, and liver transplants are sometimes the only solution. However, it can be extremely difficult to find liver donors in Egypt.
By AFP CAIRO: The American University in Cairo said Wednesday that a team of its researchers has designed a faster and cheaper test for all types of hepatitis C, which it says affects about 10 million Egyptians. The development “reduces the two-step testing process carried out over a number of days to a one-step process …